At a glance
ClinicalIndex Comparison RecordPhase 1Recruiting· 52 target
Drug / intervention
Insulin, 4 units +5 moredrug
Likely dose
Insulin, 4 unitsfrom record
Key inclusion· 3
- ✓Capable of providing informed consent
- ✓Diagnosis of optic neuropathy (glaucoma, NAION, or optic disc drusen)
- ✓Only one eye per patient selected; if both qualify, select eye with worse acuity and/or visual field
Key exclusion· 6
- ✕Pregnant or breastfeeding
- ✕Ocular pathologies other than glaucoma contributing to severe vision loss
- ✕Glucose intolerance, type 1 or 2 diabetes mellitus
- ✕Unable to perform reliable visual field
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Topical Insulin for Glaucoma and Optic Neuropathies
In Brief
A Phase 1 clinical trial evaluating Insulin, 4 units, Insulin, 20 units, and 4 other interventions for Glaucoma. Currently recruiting, targeting 52 participants across 1 site.
Detailed Summary
The purpose of this Phase 1 trial is to determine the safety over 1-2 months of topic sterile human recombinant insulin on subjects with optic neuropathies (glaucoma, ischecmic optic neuropathy, and optic disc drusen).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
Collaborators--
Timeline
Phase 1Recruiting
202220232024202520262027
First PostedJan 2022
Enrollment StartApr 2022
TodayJul 2026
Primary CompletionDec 2026
First PostedJan 25, 2022
Enrollment StartApr 1, 2022
Primary CompletionDec 31, 2026
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 4.4 years agoPrimary completion in 6 months
Interventions
Insulin, 4 unitsdrug
Topical insulin 100 U/ml, 1 drop per day
Insulin, 20 unitsdrug
Topical insulin 500 U/ml, 1 drop per day
insulin, 4 units twice dailydrug
1 drop of low dose insulin twice daily.
insulin, 20 units twice dailydrug
1 drop of high dose insulin twice daily
insulin, 4 units three times dailydrug
1 drop of low dose insulin three times daily.
insulin, 20 units three times dailydrug
1 drop of high dose insulin three times daily.